medicinsk luft air liquide 100 % medicinsk gas, komprimerad
air liquide santé international - luft, medicinsk - medicinsk gas, komprimerad - 100 % - luft, medicinsk 100 % aktiv substans - medicinsk luft
medicinsk luft nippon gases scandinavia 100 % medicinsk gas, komprimerad
nippon gases norge as - luft, medicinsk - medicinsk gas, komprimerad - 100 % - luft, medicinsk 100 % aktiv substans - medicinsk luft
medicinsk luft strandmollen 100 % medicinsk gas, komprimerad
strandmøllen a/s - luft, medicinsk - medicinsk gas, komprimerad - 100 % - luft, medicinsk 100 % aktiv substans - medicinsk luft
airapy 100 % medicinsk gas, komprimerad
linde gas - luft, medicinsk - medicinsk gas, komprimerad - 100 % - luft, medicinsk 100 % aktiv substans - medicinsk luft
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrelhydroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotiska medel - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
medicinsk lustgas air liquide 100 % medicinsk gas, flytande
air liquide santé international - dikväveoxid - medicinsk gas, flytande - 100 % - dikväveoxid 100 % aktiv substans - dikväveoxid
medicinsk lustgas nippon gases scandinavia 100 % medicinsk gas, flytande
nippon gases norge as - dikväveoxid - medicinsk gas, flytande - 100 % - dikväveoxid 100 % aktiv substans - dikväveoxid
medicinsk lustgas strandmollen 100 % medicinsk gas, flytande
strandmøllen a/s - dikväveoxid - medicinsk gas, flytande - 100 % - dikväveoxid 100 % aktiv substans - dikväveoxid
medicinsk oxygen air liquide 100 % medicinsk gas, komprimerad
air liquide santé international - oxygen - medicinsk gas, komprimerad - 100 % - oxygen 100 % aktiv substans - syre
medicinsk oxygen nippon gases scandinavia 100 % medicinsk gas, komprimerad
nippon gases norge as - oxygen - medicinsk gas, komprimerad - 100 % - oxygen 100 % aktiv substans - syre